DWP
TMO icon

Daymark Wealth Partners’s Thermo Fisher Scientific TMO Stock Holding History

Daymark Wealth Partners’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.06M Buy
10,096
+392
+4% +$188K 0.12% 134
2026
Q1 		$4.77M Buy
9,704
+1,990
+26% +$1.08M 0.15% 121
2025
Q4 		$4.47M Buy
7,714
+7,003
+985% +$3.96M 0.14% 120
2025
Q3 		$345K Buy
711
+160
+29% +$74.5K 0.01% 450
2025
Q2 		$223K Sell
551
-225
-29% -$94.1K 0.01% 519
2025
Q1 		$386K Buy
776
+186
+32% +$101K 0.02% 370
2024
Q4 		$307K Sell
590
-119
-17% -$65.4K 0.01% 405
2024
Q3 		$439K Buy
709
+90
+15% +$53.3K 0.02% 355
2024
Q2 		$342K Buy
619
+122
+25% +$69.9K 0.02% 381
2024
Q1 		$289K Buy
497
+3
+0.6% +$1.68K 0.02% 349
2023
Q4 		$262K Sell
494
-119
-19% -$57.6K 0.02% 339
2023
Q3 		$310K Sell
613
-153
-20% -$81.5K 0.02% 299
2023
Q2 		$400K Buy
766
+101
+15% +$54.5K 0.03% 259
2023
Q1 		$383K Buy
+665
New +$375K 0.05% 207

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Daymark Wealth Partners's TMO Position: Q2 2026 in Review

Daymark Wealth Partners increased its Thermo Fisher Scientific (TMO) stake by 4% in Q2 2026, buying an estimated $188K and bringing the position to 10,096 shares worth $5.06M. The position accounts for 0.12% of the portfolio, ranked #134.

Daymark Wealth Partners first reported a position in TMO in Q1 2023 and has held it in 14 quarters since. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Daymark Wealth Partners held 10,096 shares of Thermo Fisher Scientific worth $5.06M as of Q2 2026.
  • Daymark Wealth Partners bought 392 Thermo Fisher Scientific shares in Q2 2026, an estimated $188K.
  • Thermo Fisher Scientific made up 0.12% of Daymark Wealth Partners's portfolio in Q2 2026, its #134 holding.
  • Daymark Wealth Partners first reported a position in Thermo Fisher Scientific in Q1 2023 and has held it in 14 quarters since.
  • 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Daymark Wealth Partners's 13F filing for Q2 2026, filed 31 Jul 2026.